SuspendedPhase 2

Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients

NCT00787293

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Onze Lieve Vrouw Ziekenhuis Cardiovasculair Ondrezoek Aalst

Aalst, Belgium

+12 additional locations

Save this trial

Onze Lieve Vrouw Ziekenhuis Cardiovasculair Ondrezoek AalstAalst, Belgium
Centre Hospitalier Universitaire de LiègeLiège, Belgium
Institut Klinicke a Experimentalni MedicinyPrague, Czechia
Rheinisch-Westfalische Technische Hochschule Universitaetsklinikum AachenAachen, Germany
Herz-und Diabeteszentrum Nordrhein-Westfalen / Ruhr University of BochumBad Oeynhausen, Germany
Universitaet Duisburg-Essen Westdeutsches Herzzentrum Universitaetsklinikum EssenEssen, Germany
CardioVascular Center Frankfurt Sankt KatharinenFrankfurt, Germany
Albert-Ludwigs-Universitat Freiburg Mediziniche Universitätsklinikum FreiburgFreiburg im Breisgau, Germany
Städtische Klinikum Karlsruhe GmbHKarlsruhe, Germany
Klinikum Schwabing Städtisches Klinikum München GmbHMünchen, Germany
Thoraxcentrum Erasmus Medisch CentrumRotterdam, Netherlands
Universitair Medisch Centrum UtrechtUtrecht, Netherlands
Hôpital Universitaire de GenèveGeneva, Switzerland